Early Access — free while we kick the tires
EdgarHawk

BALTIMORE DAVID

Director

Director
1 filing analyzed · 1 company · Latest 2025-01-31

Companies

Company Buys Sells Direction
Regulus Therapeutics Inc. RGLS 1 0 Net buying

Activity

January 2025
high
Buy
19,610 shares
$20,787
Significance 5/10

Director BALTIMORE DAVID bought 19,610 shares of RGLS at $1.06 on 2025-01-30; now holds 22,169 shares despite company's -$14.1M net loss and -100.0% annual revenue growth.

Director BALTIMORE DAVID purchased 19,610 shares at $1.06, increasing his holdings by 766.3% from 2,559 to 22,169 shares. The company is unprofitable with net income of -$14,062,000.00 and annual revenue growth of -100.0%, with the latest quarter showing zero revenue. The stock is currently trading at $1.00, down 65.3% from its 52-week high and down 36.7% over the past 30 days. This transaction represents a material accumulation by a director at a distressed company facing severe operational headwinds, and the filing merits examination into the context of this purchase relative to any announcements, restructuring plans, or material developments that may not yet be reflected in the public price.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access